购物车
- 全部删除
- 您的购物车当前为空
ML-335 是μ-δ异构体靶向激动剂,是一种μOR-δOR 偏向配体,可以作为开发独特类型(异构体偏倚)药物的支架。ML-335是MOR(μ阿片受体)/DOR(δ阿片受体)异构体, 具有抗伤害感受活性和抑制疼痛的活性。
ML-335 是μ-δ异构体靶向激动剂,是一种μOR-δOR 偏向配体,可以作为开发独特类型(异构体偏倚)药物的支架。ML-335是MOR(μ阿片受体)/DOR(δ阿片受体)异构体, 具有抗伤害感受活性和抑制疼痛的活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 318 | 现货 | |
5 mg | ¥ 697 | 现货 | |
10 mg | ¥ 1,170 | 现货 | |
25 mg | ¥ 2,560 | 现货 | |
50 mg | ¥ 4,480 | 现货 | |
100 mg | ¥ 6,490 | 现货 | |
500 mg | ¥ 12,800 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 773 | 现货 |
产品描述 | ML-335 is a μ-δ isomer-targeted agonist, a μOR-δOR-biased ligand that can serve as a scaffold for the development of unique types of (isomer-biased) drugs.ML-335 is a MOR (μ-opioid receptor)/DOR (δ-opioid receptor) heterodimer, with anti-injury sensory activity and pain inhibitory activity. |
靶点活性 | μ opioid receptor:0.125 µM(EC50) |
体内活性 | CYM51010(ML-335)(皮下注射;SNL大鼠)以剂量相关的方式抑制了机械性高敏感(EC50:1.09 mg/kg),同时也逆转了热痛觉过敏并减轻了持续性疼痛(2 mg/kg,皮下注射)[1]。 |
分子量 | 408.53 |
分子式 | C25H32N2O3 |
CAS No. | 1069498-96-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 9.0 mg/mL (22.1 mM) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.